NIX

NALIDIXIC ACID

Find entries where: NIX

as a non-polymer is covalently linked to polymer or other heterogen groups 1 entries

Find related ligands:

Chemical Component Summary
Name	NALIDIXIC ACID
Identifiers	1-ethyl-7-methyl-4-oxo-1,8-naphthyridine-3-carboxylic acid
Formula	C₁₂ H₁₂ N₂ O₃
Molecular Weight	232.235
Type	NON-POLYMER
Isomeric SMILES	CCN1C=C(C(=O)c2c1nc(cc2)C)C(=O)O
InChI	InChI=1S/C12H12N2O3/c1-3-14-6-9(12(16)17)10(15)8-5-4-7(2)13-11(8)14/h4-6H,3H2,1-2H3,(H,16,17)
InChIKey	MHWLWQUZZRMNGJ-UHFFFAOYSA-N

Chemical Details
Formal Charge	0
Atom Count	29
Chiral Atom Count	0
Bond Count	30
Aromatic Bond Count	11

Drug Info: DrugBank

DrugBank ID	DB00779
Name	Nalidixic acid
Groups	approved investigational
Description	Nalidixic acid is a synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum. It is an inhibitor of the A subunit of bacterial DNA gyrase.
Synonyms	1-Ethyl-7-methyl-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid 1-Aethyl-7-methyl-1,8-naphthyridin-4-on-3-karbonsaeure Acidum nalidixicum Acide nalidixique Acido nalidixico Nalidixinsäure 1-ethyl-1,4-dihydro-7-methyl-4-oxo-1,8-naphthyridine-3-carboxylic acid 1,4-dihydro-1-ethyl-7-methyl-4-oxo-1,8-naphthyridine-3-carboxylic acid 1-ethyl-7-methyl-1,4-dihydro-1,8-naphthyridin-4-one-3-carboxylic acid Nalidixic acid 3-carboxy-1-ethyl-7-methyl-1,8-naphthyridin-4-one
Brand Names	NegGram
Indication	For the treatment of urinary tract infections caused by susceptible gram-negative microorganisms, including the majority of <i>E. Coli</i>, <i>Enterobacter</i> species, <i>Klebsiella</i> species, and <i>Proteus</i> species.
Categories	4-Quinolones Agents that reduce seizure threshold Anti-Bacterial Agents Anti-Infective Agents Antibacterials for Systemic Use Antiinfectives for Systemic Use Cytochrome P-450 CYP1A2 Inhibitors Cytochrome P-450 CYP1A2 Inhibitors (strength unknown) Cytochrome P-450 Enzyme Inhibitors Drugs causing inadvertant photosensitivity Enzyme Inhibitors Fluoroquinolones Heterocyclic Compounds, Fused-Ring Moderate Risk QTc-Prolonging Agents Naphthyridines OAT1/SLC22A6 inhibitors Photosensitizing Agents QTc Prolonging Agents Quinolines Quinolones Topoisomerase II Inhibitors Topoisomerase Inhibitors
ATC-Code	J01MB02
CAS number	389-08-2

Drug Targets

Name	Target Sequence	Pharmacological Action	Actions
DNA	-	unknown	other
Tryptophan 2,3-dioxygenase	MSGCPFLGNNFGYTFKKLPVEGSEEDKSQTGVNRASKGGLIYGNYLHLEK...	unknown	inhibitor
Cytochrome P450 1A2	MALSQSVPFSATELLLASAIFCLVFWVLKGLRPRVPKGLKSPPEPWGWPL...	unknown	inhibitor
Solute carrier family 22 member 6	MAFNDLLQQVGGVGRFQQIQVTLVVLPLLLMASHNTLQNFTAAIPTHHCR...	unknown	inhibitor

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource Name	Reference
PubChem	4421
ChEMBL	CHEMBL5
ChEBI	CHEBI:100147
CCDC/CSD	DIYYOB, NALIDX01, DIYYUH, DIYZAO, DIYZES, ZEXWIK, ZEXVUV, ZEXWAC, NALIDX03, ZEXWEG, NALIDX
COD	4510282, 4510283, 4510284, 4510285, 4506808, 4506809, 4506812

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.

Prepare Data

Validate Data

Deposit Data

Help and Resources

NIX

NALIDIXIC ACID

Chemical Component Summary

Chemical Details

Drug Info: DrugBank

Drug Targets

Related Resource References